Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Journal of the American Society of Hypertension : JASH
|
June 11, 2014
Long-term renin-angiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms
Daniel Silverberg, Anan Younis, Naphtali Savion, et al.
Frontiers in Plant Science
|
February 27, 2023
Influence of late pruning practice on two red skin grapevine cultivars in a semi-desert climate
Corrado Perin, Pankaj Kumar Verma, Gil Harari, et al.
Multiple Sclerosis and Related Disorders
|
November 27, 2020
Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: Results of an online survey
Alon Kalron, Mark Dolev, Michal Greenberg-Abrahami, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
January 23, 2023
Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis
Shay Menascu, Michal Siegel-Kirshenbaum, Sapir Dreyer-Alster, et al.
Frontiers in Nutrition
|
April 3, 2023
Bioavailability of calcium in an enriched postbiotic system compared to calcium citrate in healthy postmenopausal females; A randomized, double-blind, comparator-controlled, crossover study
Marina Friling, Adi Haber, Sharon Furman-Assaf, et al.
Journal of Neuroengineering and Rehabilitation
|
December 20, 2021
Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a
Shay Menascu, Roy Aloni, Mark Dolev, et al.
Therapeutic Advances in Neurological Disorders
|
May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Therapeutic Advances in Neurological Disorders
|
June 9, 2021
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Journal of Neurology
|
March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod
Anat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 19, 2016
Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial
Ilan Ben-Zvi, Olga Kukuy, Eitan Giat, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Journal of the American Society of Hypertension : JASH
|
June 11, 2014
Long-term renin-angiotensin blocking therapy in hypertensive patients with normal aorta may attenuate the formation of abdominal aortic aneurysms
Daniel Silverberg, Anan Younis, Naphtali Savion, et al.
Frontiers in Plant Science
|
February 27, 2023
Influence of late pruning practice on two red skin grapevine cultivars in a semi-desert climate
Corrado Perin, Pankaj Kumar Verma, Gil Harari, et al.
Multiple Sclerosis and Related Disorders
|
November 27, 2020
Physical activity behavior in people with multiple sclerosis during the COVID-19 pandemic in Israel: Results of an online survey
Alon Kalron, Mark Dolev, Michal Greenberg-Abrahami, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical
|
January 23, 2023
Intravenous immunoglobulin treatment during pregnancy and the post-partum period in women with multiple sclerosis: A prospective analysis
Shay Menascu, Michal Siegel-Kirshenbaum, Sapir Dreyer-Alster, et al.
Frontiers in Nutrition
|
April 3, 2023
Bioavailability of calcium in an enriched postbiotic system compared to calcium citrate in healthy postmenopausal females; A randomized, double-blind, comparator-controlled, crossover study
Marina Friling, Adi Haber, Sharon Furman-Assaf, et al.
Journal of Neuroengineering and Rehabilitation
|
December 20, 2021
Targeted cognitive game training enhances cognitive performance in multiple sclerosis patients treated with interferon beta 1-a
Shay Menascu, Roy Aloni, Mark Dolev, et al.
Therapeutic Advances in Neurological Disorders
|
May 26, 2021
Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Therapeutic Advances in Neurological Disorders
|
June 9, 2021
Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
Anat Achiron, Mathilda Mandel, Sapir Dreyer-Alster, et al.
Journal of Neurology
|
March 2, 2022
Immune response to the third COVID-19 vaccine dose is related to lymphocyte count in multiple sclerosis patients treated with fingolimod
Anat Achiron, Mathilda Mandel, Michael Gurevich, et al.
Arthritis & Rheumatology (Hoboken, N.J.)
|
November 19, 2016
Anakinra for Colchicine-Resistant Familial Mediterranean Fever: A Randomized, Double-Blind, Placebo-Controlled Trial
Ilan Ben-Zvi, Olga Kukuy, Eitan Giat, et al.
Page
of 4